Sylentis Competitors and Similar CompaniesClear all
Lexicon Pharmaceuticals's competitors and similar companies include Omega Therapeutics and AnGes.
 Lexicon Pharmaceuticals Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology. |  AnGes AnGes is a biopharmaceutical company specializing in R&D and practical application of genetic medicine. | ||
Founding Date | Founding Date 1995 | Founding Date 2017 | Founding Date 1999 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations The Woodlands, US HQ Jersey, JE Atlanta, US Bernards, US Birmingham, US Boston, US Charlotte, US see more | Locations Cambridge, US HQ | Locations Ibaraki, JP HQ Fujisawa, JP Ibaraki, JP Kawasaki, JP Minato City, JP Bethesda, US |
Employees | Employees 20216% increase | Employees 60 | Employees 5562% decrease |
Valuation ($) | Valuation ($) 737.4 m | Valuation ($) 68.4 m | Valuation ($) 78.3 m |
Financial | |||
Revenue (est.) | Revenue (est.) $49.8m (FY, 2025) | Revenue (est.) $3.1m (FY, 2023) | Revenue (est.) ¥874.1m (FY, 2025) |
Cost of goods | Cost of goods $274k (FY, 2025) | Cost of goods N/A | Cost of goods ¥499.9m (FY, 2025) |
Gross profit | Gross profit $49.5m (FY, 2025) | Gross profit N/A | Gross profit ¥374.2m (FY, 2025) |
Net income | Net income ($50.3m) (FY, 2025) | Net income ($97.4m) (FY, 2023) | Net income (¥5.1b) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 244.7m | Total funding raised $ 211m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Omega Therapeutics
HQ
Cambridge, US
Employees
60
Omega Therapeutics is an epigenomic medicine company.
View companyAnGes
HQ
Ibaraki, JP
Employees
55
AnGes is a biopharmaceutical company specializing in R&D and practical application of genetic medicine.
View company